Bench-to-bedside review: Pulmonary-renal syndromes - An update for the intensivist

Critical Care

Volumn 11, Issue 3, 2007, Pages

  Papiris, Spyros A ^a   Manali, Effrosyni D ^a   Kalomenidis, Ioannis ^a   Kapotsis, Giorgios E ^a   Karakatsani, Anna ^a   Roussos, Charis ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ANTICOAGULANT AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; ETANERCEPT; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; LEFLUNOMIDE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUTROPHIL CYTOPLASMIC ANTIBODY; PENICILLAMINE; PREDNISONE; RITUXIMAB; SALAZOSULFAPYRIDINE; THYMOCYTE ANTIBODY; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ANTIGEN ANTIBODY COMPLEX; ANTIPHOSPHOLIPID SYNDROME; BONE MARROW SUPPRESSION; BRONCHOSCOPY; CHURG STRAUSS SYNDROME; COMPUTER ASSISTED TOMOGRAPHY; CRITICALLY ILL PATIENT; DIFFERENTIAL DIAGNOSIS; DRUG DOSE REDUCTION; DRUG MECHANISM; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; GONADAL DISEASE; GOODPASTURE SYNDROME; HEMORRHAGIC CYSTITIS; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE TEST; INFECTION; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LOW DRUG DOSE; LUNG BIOPSY; LUNG DISEASE; LUNG HEMORRHAGE; LUNG INSUFFICIENCY; LUNG KIDNEY SYNDROME; LUPUS ERYTHEMATOSUS NEPHRITIS; MALIGNANT NEOPLASTIC DISEASE; MICROSCOPIC POLYANGIITIS; NECROTIZING ARTERITIS; OPPORTUNISTIC INFECTION; PATHOPHYSIOLOGY; PERCUTANEOUS BIOPSY; PLASMA TRANSFUSION; PLASMAPHERESIS; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; REVIEW; SMALL VESSEL VASCULITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC VASCULITIS; THORAX RADIOGRAPHY; THROMBOTIC THROMBOCYTOPENIC PURPURA; UNSPECIFIED SIDE EFFECT; WEGENER GRANULOMATOSIS; BLEEDING; GLOMERULONEPHRITIS; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE; LUNG ALVEOLUS; METABOLISM; METHODOLOGY; PATHOLOGY; SYNDROME;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; GLOMERULONEPHRITIS; HEMORRHAGE; HUMANS; IMMUNOSUPPRESSION; INTENSIVE CARE; PULMONARY ALVEOLI; SYNDROME;

EID: 40749151484     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc5778     Document Type: Review

References (118)

1. Gallagher H Kwan J Jayne RW Pulmonary renal syndrome: A 4-year, single center experience Am J Kidney Dis 2002, 38:42-47. 11774100
2. Goodpasture EW The significance of certain pulmonary lesions in relation to the aetiology of pneumonia Am J Med Sci 1919, 158:863-870. 10.1097/ 00000441-191911000-00012
3. Stanton MC Tange JD Goodpasture's syndrome (pulmonary haemorrhage associated with glomerulonephritis) Australas Ann Med 1958, 7:132-144. 13546112
4. Lerner RA Glassock KJ Dixon FJ The role of antiglomerular basement membrane antibody in the pathogenesis of human glomerulonephritis J Exp Med 1967, 126:989-1004. 10.1084/jem.126.6.989 4964566
5. Specks U Diffuse alveolar hemorrhage syndromes Curr Opin Rheumatol 2001, 13:12-17. 10.1097/00002281-200101000-00003 11148710
6. Collard HR Schwarz MI Diffuse alveolar hemorrhage Clin Chest Med 2004, 25:583-592. 10.1016/j.ccm.2004.04.007 15331194
7. Wiik A Autoantibodies in vasculitis Arthritis Res Ther 2003, 5:147-152. 165052 12723981 10.1186/ar758
8. Langford C Balow JE New insights into the immunopathogenesis and treatment of small vessel vasculitis of the kidney Curr Opin Nephrol Hypertens 2003, 12:267-272. 10.1097/00041552-200305000-00007 12698064
9. Brown KK Pulmonary vasculitis Proc Am Thorac Soc 2006, 3:48-57. 10.1513/ pats.200511-120JH 16493151
10. Rodriguez W Hanania N Guy E Guntupalli J Pulmonary-renal syndromes in the intensive care unit Crit Care Clin 2002, 18:881-895. 10.1016/ S0749-0704(02)00029-5 12418445
11. Merkel PA Choi H Niles JL Evaluation and treatment of vasculitis in the critically ill patient Crit Care Clin 2002, 18:321-344. 10.1016/ S0749-0704(01)00006-9 12053837
12. Camargo JF Tobon GJ Fonseca N Diaz JL Uribe M Molina F Anaya J-M Autoimmune rheumatic diseases in the intensive care unit: Experience from a tertiary referral hospital and review of the literature Lupus 2005, 14:315-320. 10.1191/0961203305lu2082oa 15864918
13. Semple D Keogh J Forni L Venn R Clinical review: Vasculitis on the intensive care unit-part 1: Diagnosis Crit Care 2005, 9:92-97. 1065092 15693990 10.1186/cc2936
14. Griffith M Brett S The pulmonary physician in critical care illustrative case 3: Pulmonary vasculitis Thorax 2003, 58:543-546. 10.1136/ thorax.58.6.543 12775874
15. Davies DJ Small vessel vasculitis Cardiovasc Pathol 2005, 14:335-346. 10.1016/j.carpath.2005.08.001 16286046
16. Erlich JH Sevastos J Pussell B Goodpasture's disease: Antiglomerular basement membrane disease Nephrology 2004, 9:49-51. 10.1111/ j.1440-1797.2004.00244.x 15056260
17. Lau K Wyatt R Glomerulonephritis Adolesc Med 2005, 16:67-85. 10.1016/ j.admecli.2004.09.008
18. G Pardo V Leclercq B Lenz O Tozman E O'Nan P Roth Sequential therapies for proliferative lupus nephritis N Engl J Med 2004, 350:971-980. 10.1056/NEJMoa031855 14999109
19. Salama AD Levy J Lightstone L Pusey CD Goodpasture's disease Lancet 2001, 358:917-920. 10.1016/S0140-6736(01)06077-9 11567730
20. Hudson BG Tryggvason K Sundaramoorthy M Neilson EG Alport's syndrome, Goodpasture's syndrome, and type IV collagen N Engl J Med 2003, 348:2543-2556. 10.1056/NEJMra022296 12815141
21. Bombassei GJ Kaplan AA The association between hydrocarbon exposure and anti-glomerular basement membrane antibody-mediated disease (Goodpasture's syndrome) Am J Ind Med 1992, 21:141-153. 10.1002/ ajim.4700210204 1536151
22. Phelps RG Jones V Turner AN Rees AJ Properties of HLA class II molecules divergently associated with Goodpasture's disease Int Immunol 2000, 12:1135-1143. 10.1093/intimm/12.8.1135 10917888
23. Lou YH Anti-GBM glomerulonephritis: A T cell-mediated autoimmune disease Arch Immunol Ther Exp 2004, 52:96-103. 15179323
24. Sheerin NS Springall T Carroll MC Sacks SH Protection against antiglomerular basement membrane (GBM)-mediated nephritis in C3 and C4 deficient mice Clin Exp Immunol 1997, 110:403-409. 10.1046/ j.1365-2249.1997.4261438.x 9409643
25. Meyers KE Allen J Gehret J Jacobovits A Gallo M Neilson EG Hopfer H Kalluri R Madaio MP Human antiglomerular basement membrane autoantibody disease in Xenomouse II Kidney Int 2002, 61:1666-1673. 10.1046/ j.1523-1755.2002.00312.x 11967016
26. Csernok E Anti-neutrophil cytoplasmic antibodies and pathogenesis of small vessel vasculitides Autoimmun Rev 2003, 2:158-164. 10.1016/ S1568-9972(03)00010-7 12848957
27. Frankel S Cosgrove G Fischer A Meehan RT Brown KK Update in the diagnosis and management of pulmonary vasculitis Chest 2006, 129:452-465. 10.1378/chest.129.2.452 16478866
28. Bacon PA The spectrum of Wegener's granulomatosis and disease relapse N Engl J Med 2005, 352:330-332. 10.1056/NEJMp048338 15673799
29. Langford C Hoffman G Wegener's granulomatosis Thorax 1999, 54:629-637. 10377211
30. Savige J Davies D Falk R Jennette JC Wiik A Antineutrophil cytoplasmic antibodies and associated diseases: A review of the clinical and laboratory features Kidney Int 2000, 57:846-862. 10.1046/ j.1523-1755.2000.057003846.x 10720938
31. Schwarz M Brown K Small vessel vasculitis of the lung Thorax 2000, 55:502-510. 10.1136/thorax.55.6.502 10817800
32. Guillevin L Cohen P Gayraud M Lhote F Jarrousse B Casassus P Churg Strauss syndrome: Clinical study and long-term follow-up of 96 patients Medicine 1999, 78:26-37. 10.1097/00005792-199901000-00003 9990352
33. Davies DJ Moran JE Niall JF Ryan GB Segmental necrotizing glomerulonephritis with antineutrophil antibody: Possible arbovirus aetiology? [Short report] BMJ 1982, 285:606. 1499415 6297657
34. van der Woude FJ Rasmussen N Lobatto S Wiik A Permin H van ES LA van der Giessen M van der Hem GK The TH Autoantibodies against neutrophils and monocytes: Tool for diagnosis and marker of disease activity in Wegener's granulomatosis Lancet 1985, 23:425-429. 10.1016/ S0140-6736(85)91147-X 2857806
35. Bosch X Guilabert A Font J Antineutrophil cytoplasmic antibodies Lancet 2006, 368:404-418. 10.1016/S0140-6736(06)69114-9 16876669
36. Falk RJ Jennette JC Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis N Engl J Med 1988, 318:1651-1657. 2453802
37. Niles JL McCluskey RT Ahmad MF Arnaout MA Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase Blood 1989, 74:1888-1893. 2679910
38. Xiao H Heeringa P Hu P Liu Z Zhao M Aratani Y Maeda N Falk RJ Jennette JC Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice J Clin Invest 2002, 110:955-963. 151154 12370273 10.1172/JCI200215918
39. Schlieben DJ Korbet SM Kimura RE Schwartz MM Lewis EJ Pulmonary-renal syndrome in a newborn with placental transmission of ANCAs Am J Kidney Dis 2005, 45:758-761. 10.1053/j.ajkd.2005.01.001 15806479
40. Jennette JC Xiao H Falk RJ Pathogenesis of vascular inflammation by antineutrophil cytoplasmic antibodies J Am Soc Nephrol 2006, 17:1235-1242. 10.1681/ASN.2005101048 16624929
41. Pfister H Ollert M Frolich LF Quintanilla-Martinez L Colby TV Specks U Jenne DE Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo Blood 2004, 104:1411-1418. 10.1182/blood-2004-01-0267 15150076
42. Little MA Smyth CL Yadav R Ambrose L Cook HT Nourshargh S Pusey CD Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte microvascular interactions in vivo Blood 2005, 106:2050-2058. 10.1182/blood-2005-03-0921 15933057
43. Xiao H Heeringa P Liu Z Huugen D Hu P Maeda N Falk PJ Jennette JC The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies Am J Pathol 2005, 167:39-45. 1603451 15972950
44. Seo P Stone J The antineutrophil cytoplasmic antibody-associated vasculitides Am J Med 2004, 117:39-50. 10.1016/j.amjmed.2004.02.030 15210387
45. Booth A Pusey C Jayne D Renal vasculitis - an update in 2004 Nephrol Dial Transplant 2004, 19:1964-1968. 10.1093/ndt/gfh318 15213321
46. Niles JL Böttinger EP Saurina GR Kelly KJ Pan G Collins AB McCluskey RT The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition Arch Intern Med 1996, 156:440-445. 10.1001/ archinte.156.4.440 8607730
47. Green R Ruoss S Kraft S Dunkan SR Berry GJ Raffin TA Pulmonary capillaritis and alveolar hemorrhage Chest 1996, 110:1305-1316. 8915239
48. Choi HK Merkel PA Walker AM Niles JL Drug associated anti-neutrophil cytoplasmic antibody positive vasculitis Arthritis Rheum 2000, 43:405-413. 10.1002/1529-0131(200002)43:2<405::AID-ANR22>3.0.CO;2-5 10693882
49. Schwarz MI Fontenot AP Drug-induced diffuse alveolar hemorrhage syndromes and vasculitis Clin Chest Med 2004, 25:133-140. 10.1016/ S0272-5231(03)00139-4 15062605
50. Bonaci-Nikolic B Nikolic MM Andrejevic S Zoric S Bukilica M Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: Comparison with idiopathic ANCA vasculitides Arthritis Res Ther 2005, 7:R1072-R1081. 1257438 16207324 10.1186/ar1789
51. Jayne DR Marshall PD Jones SJ Lockwood CM Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis Kidney Int 1990, 37:965-970. 2179617
52. Bosch X Mirapeix E Font J Lopez-Soto A Rodriguez R Vivancos J Revert L Ingelmo M Urbano-Marquez A Prognostic implication of anti-neutrophil cytoplasmic autoantibodies with myeloperoxidase specificity in antiglomerular basement disease Clin Nephrol 1991, 36:107-113. 1657470
53. Serratrice J Chiche L Dussol B Granel B Daniel L Jego-Desplat S Disdier P Swiader L Berland Y Weiller PJ Sequential development of perinuclear ANCA-associated vasculitis and anti-glomerular basement membrane glomerulonephritis Am J Kidney Dis 2004, 43:e26-e30. 10.1053/ j.ajkd.2003.11.019 14981638
54. Hughson M Zhi H Henegar J McMurray R Alveolar hemorrhage and renal microangiopathy in systemic lupus erythematosus Arch Pathol Lab Med 2001, 125:475-483. 11260619
55. Keane M Lynch J Pleuropulmonary manifestations of systemic lupus erythematosus Thorax 2000, 55:159-166. 10.1136/thorax.55.2.159 10639536
56. Bar J Ehrenfeld M Rozenman J Perelman M Sidi Y Gur H Pulmonary renal syndrome in systemic sclerosis Semin Arthritis Rheum 2001, 30:403-410. 10.1053/sarh.2001.21904 11404823
57. Wutzl A Foley R O'Driscoll B Reeve RS Chisholm R Herrick AL Microscopic polyangiitis presenting as pulmonary renal syndrome in a patient with long-standing diffuse cutaneous systemic sclerosis and antibodies to myeloperoxidase Arthritis Care Res 2001, 45:533-536. 10.1002/ 1529-0131(200112)45:6<533::AID-ART379>3.0.CO;2-D
58. Levine JS Branch DW Rauch J The antiphospholipid syndrome N Engl J Med 2002, 346:752-763. 10.1056/NEJMra002974 11882732
59. Hanly JG Antiphospholipid syndrome: An overview CMAJ 2003, 168:1675-1682. 161613 12821621
60. Gezer S Antiphospholipid syndrome Dis Mon 2003, 49:696-741. 14679358 10.1016/S0011-5029(03)00184-6
61. Deane KD West SG Antiphospholipid antibodies as a cause of pulmonary capillaritis and diffuse alveolar hemorrhage: A case series and literature review Semin Arthritis Rheum 2005, 35:154-165. 10.1016/ j.semarthrit.2005.05.006 16325656
62. Panoskaltsis N Derman MP Perillo I Brennan JK Thrombotic thrombocytopenic purpura in Pulmonary-renal syndromes Am J Hematol 2000 65 50 55 10.1002/1096-8652(200009)65:1<50::AID-AJH9>3.0.CO;2-5 10936864
63. George JN Thrombotic thrombocytopenic purpura N Engl J Med 2006, 354:1927-1935. 10.1056/NEJMcp053024 16672704
64. Levy GG Nichols WC Lian EC Foroud T McClintick JN McGee B Yang AY Siemieniak DR Stark KR Gruppo R Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura Nature 2001, 413:488-494. 10.1038/35097008 11586351
65. Soejima K Nakagaki T Interplay between ADAMTS 13 and von Willebrand factor in inherited and acquired thrombotic microangiopathies Semin Hematol 2005, 42:56-62. 10.1053/j.seminhematol.2004.09.008 15662617
66. Tsai HM Rice L Sarode R Chow TW Moake JL Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura Ann Intern Med 2000, 132:794-799. 10819702
67. Fontana S Kremer Hovinga JA Lammle B Mansouri Taleghani B Treatment of thrombotic thrombocytopenic purpura Vox Sang 2006, 90:245-254. 10.1111/ j.1423-0410.2006.00747.x 16635066
68. Pourrat O Bureau JM Hira M Martin-Barbaz F Descamps JM Robert R Pronostic des maladies systémiques admises en réanimation: étude rétrospective de 39 séjours Rev Méd Intern 2000, 21:147-151. 10.1016/S0248-8663(00)88243-0 10703070
69. Cruz BA Ramanoelina J Mahr A Cohen P Mouthon L Cohen Y Hoang P Guillevin L Prognosis and outcome of 26 patients with systemic necrotizing vasculitis admitted to the intensive care unit Rheumatology 2003, 42:1183-1188. 10.1093/rheumatology/keg322 12777637
70. Gallagher H Kwan JT Jayne DR Pulmonary-renal syndrome: A 4-year, single-center experience Am J Kidney Dis 2002, 39:42-47. 11774100
71. Bucciarelli S Espinosa G Asherson RA Cervera R Claver G Gomez-Puerta JA Ramos-Casals M Ingelmo M Catastrophic Antiphospholipid Syndrome Registry Project Group The acute respiratoty distress syndrome in catastrophic antiphospholipid syndrome: Analysis of a series of 47 patients Ann Rheum Dis 2006, 65:81-86. 10.1136/ard.2005.037671 15919677
72. Manganelli P Fietta P Carotti M Pesci A Salaffi F Respiratory system involvement in systemic vasculitides Clin Exp Rheumatol 2006, 24:S48-S59. 16859597
73. Bouachour G Roy PM Tirot P Quérin O Gouello JR Alquier P Prognosis of systemic diseases diagnosed in intensive care units [in French] Presse Méd 1996, 25:837-841.
74. Cervera R Asherson RA Acevedo ML Gomez-Puerta JA Espinosa G de la Red G Gil V Ramos-Casals M Garcia-Carrasco M Ingelmo M Font J Antiphospholipid syndrome associated with infections: Clinical and microbiological characteristics of 100 patients Ann Rheum Dis 2004, 63:1312-1317. 10.1136/ard.2003.014175 15361392
75. Bowley NB Steiner RE Chin WS The chest X-ray in antiglomerular basement membrane antibody disease (Goodpasture's syndrome) Clin Radiol 1979, 30:419-429. 10.1016/S0009-9260(79)80223-8 466941
76. Papiris SA Manoussakis MN Drosos A Kontogiannis D Constantopoulos SH Moutsopoulos HM Imaging of thoracic Wegener's granulomatosis: The computed tomographic appearance Am J Med 1992, 93:529-536. 10.1016/ 0002-9343(92)90581-U 1442856
77. Ando Y Okada F Matsumoto S Mori H Thoracic manifestation of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) related disease J Comput Assist Tomogr 2004, 28:710-716. 10.1097/ 01.rct.0000135280.79012.c7 15480049
78. Jennings C King T Tuder R Cherniack RM Schwarz MI Diffuse alveolar hemorrhage with underlying isolated, pauciimmune pulmonary capillaritis Am J Respir Crit Care Med 1997, 155:1101-1109. 9116994
79. Jennette JC Wilkman AS Falk RJ Diagnostic predictive value of ANCA serology [editorial] Kidney Int 1998, 537:96-798. 9507231
80. Sinico RA Radice A Corace C Sabadini E Bollini B Antiglomerular basement membrane antibodies in the diagnosis of Goodpasture syndrome: A comparison of different assays Nephrol Dial Transplant 2006, 21:397-401. 10.1093/ndt/gfi230 16234289
81. Salama A Dougan T Levy J Cook HT Morgan SH Naudeer S Maidment G George AJ Evans D Lightstone L Pussey CD Goodpasture's disease in the absence of circulating anti-glomerular membrane antibodies as detected by standard techniques Am J Kidney Dis 2002, 39:1162-1167. 10.1053/ ajkd.2002.33385 12046026
82. Hellmann M Gerhardt T Rabe C Haas S Sauerbruch T Woitas RP Goodpasture's syndrome with massive pulmonary haemorrhage in the absence of circulating anti-GBM antibodies? Nephrol Dial Transplant 2006, 21:526-529. 10.1093/ndt/gfi279 16303779
83. Travis WD Hoffman GS Leavitt RY Pass HI Fauci AS Surgical pathology of the lung in Wegener's granulomatosis. Review of 87 open lung biopsies from 67 patients Am J Surg Pathol 1991, 15:315-333. 2006712
84. Frankel SK Sullivan EJ Brown KK Vasculitis: Wegener granulomatosis, Churg-Strauss syndrome, microscopic polyangiitis, polyarteritis nodosa, and Takayasu arteritis Crit Care Clin 2002, 18:855-879. 10.1016/ S0749-0704(02)00031-3 12418444
85. Sano K Sakaguchi N Ito M Koyama M Kobayashi M Hotchi M Histological diversity of vasculitic lesions in MPO-ANCA positive autopsy cases Pathol Intern 2001, 51:460-466. 10.1046/j.1440-1827.2001.01225.x
86. Katzenstein AL Diagnostic features and differential diagnosis of Churg-Strauss syndrome in the lung. A review Am J Clin Pathol 2000, 114:767-772. 10.1309/F3FW-J8EB-X913-G1RJ 11068552
87. Savige J Dimech W Fritzler M Goeken J Hagen EC Jennette JC McEvoy R Pucey C Pollack W Trevisin M Addentum to the International Consencus Statement on testing and reporting antineutrophil cytoplasmic antibodies. Quality control guidelines, comments, and recommendations for testing in other autoimmune diseases Am J Clin Pathol 2003, 120:312-318. 10.1309/WAEP-ADW0-K4LP-UHFN 14502794
88. Sable-Fourtassou R Cohen P Mahr A Pagnoux C Mouthon L Jayne D Blockmans D Cordier JF Delaval P Puechal X Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome Ann Intern Med 2005, 143:632-638. 16263885
89. Falk RJ Jennette JC Thoughts about the classification of small vessel vasculitis J Nephrol 2004, 17(Suppl 8):S3-S9. 15599883
90. Vassilopoulos D Hoffman G Clinical utility of testing for anti-neutrophil cytoplasmic antibodies Clin Diagn Lab Immunol 1999, 6:645-651. 95747 10473510
91. Jennette JC Falk RJ The pathology of vasculitis involving the kidney Am J Kidney Dis 1994, 24:130-141. 8023818
92. Agard C Mouthon L Mahr A Guillevin L Microscopic polyangiitis and polyarteritis nodosa: How and when do they start? Arthritis Rheum 2003, 49:709-715. 10.1002/art.11387 14558058
93. Niles JA A renal biopsy is essential for the management of ANCA-positive patients with glomerulonephritis, the contra view Sarcoidosis Vasc Diffuse Lung Dis 1996, 13:232-234. 8946589
94. Tesar V Rihova Z Jancova E Rysova R Merta M European randomized trials: current treatment strategies in ANCA-positive renal vasculitis-lessons from European randomized trials Nephrol Dial Transplant 2003, 18:v2-v4. 10.1093/ndt/gfg1032 12817056
95. Hogan S Falk RJ Chin H Cai J Jennette CE Jennette JC Nachman PH Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small vessel vasculitis Ann Intern Med 2005, 143:621-631. 16263884
96. Rihova Z Jancova E Merta M Tesar V Daily oral versus pulse intravenous cyclophosphamide in the therapy of ANCA-associated vasculitis - preliminary single center experience Prague Med Rep 2004, 105:64-68. 15354947
97. Gaskin G Pusey C Plasmapheresis in antineutrophil cytoplasmic antibody-associated systemic vasculitis Ther Apher 2001, 5:176-181. 10.1046/j.1526-0968.2001.00300.x 11467753
98. Klemmer P Chalermskulrat W Reif M Hogan SL Henke DC Falk RJ Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small vessel vasculitis Am J Kidney Dis 2003, 42:1149-1153. 10.1053/ j.ajkd.2003.08.015 14655185
99. Ahmed SH Aziz T Cochran J Highland K Use of extracorporeal membrane oxygenation in a patient with diffuse alveolar hemorrhage Chest 2004, 126:305-309. 10.1378/chest.126.1.305 15249477
100. Henke DC Falk RJ Gabriel DA Successful treatment of diffuse alveolar hemorrhage with activated factor VII Ann Intern Med 2004, 140:493-494. 15023729
101. Jayne D Rasmussen N Andrassy K Bacon P Tervaert JW Dadoniene J Ekstrand A Gaskin G Gregorini G de Groot K A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies N Engl J Med 2003, 349:36-44. 10.1056/NEJMoa020286 12840090
102. White ES Lynch JP Pharmacological therapy for Wegener's granulomatosis Drugs 2006, 66:1209-1228. 10.2165/00003495-200666090-00004 16827598
103. Booth A Harper L Hammad T Bacon P Griffith M Levy J Savage C Pusey C Jayne D Prospective study of TNF alpha blockade with infliximab in antineutrophil cytoplasmic antibody-assocaited systemic vasculitis J Am Soc Nephrol 2004, 15:717-721. 10.1097/01.ASN.0000114554.67106.28 14978174
104. Lamprecht P Voswinkel J Lilienthal T Nolle B Heller M Gross WL Gause A Effectiveness of TNF-alpha blockade with infliximab in refractory Wegener's granulomatosis Rheumatology (Oxford) 2002, 41:1303-1307. 10.1093/rheumatology/41.11.1303 12422004
105. Wegener's Granulomatosis Etanercept Trial (WGET) Research Group Etanercept plus standard therapy for Wegener's granulomatosis N Engl J Med 2005, 352:351-361. 10.1056/NEJMoa041884 15673801
106. Feldman M Pusey CD Is there a role for TNF-alpha in anti-neutrophil cytoplasmic antibody-associated vasculitis? Lessons fron other chronic inflammatory diseases J Am Soc Nephrol 2006, 17:1243- 1252. 10.1681/ ASN.2005121359 16624928
107. Stasi R Stipa E del Poeta GD Amadori S Newland AC Provan D Long term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab Rheumatology (Oxford) 2006, 45:1432-1436. 10.1093/rheumatology/kel098 16632482
108. Antoniu SA Rituximab for refractory Wegener's granulomatosis Exp Opin Invest Drugs 2006, 15:1115-1117. 10.1517/13543784.15.9.1115 16916277
109. Nowack R Gobel U Klooker P Hergesell O Andrassy K van der Woude FJ Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: A pilot study in 11 patients with renal involvement J Am Soc Nephrol 1999, 10:1965-1971. 10477149
110. Langford CA Talar-Williams C Sneller MC Mycophenolate mofetil for remission maintenance in the treatment of Wegener's granulomatosis Arthritis Rheum 2004, 51:278-283. 10.1002/art.20240 15077273
111. Koukoulaki M Jayne DR Mycophenolate mofetil in anti-neutrophil cytoplasm antibodies-associated systemic vasculitis Nephron Clin Pract 2006, 102:c100-c107. 10.1159/000089667 16286784
112. Metzler C Fink C Lamprecht P Gross WL Reinhold-Keller E Maintenance of remission with leflunomide in Wegener's granulomatosis Rheumatology (Oxford) 2004, 43:315-320. 10.1093/rheumatology/keh009 14963200
113. Schmitt WH Hagen EC Neumann I Nowack R Flores-Suarez LF van der Woude FJ European Vasculitis Study Group Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG): An open study in 15 patients Kidney Int 2004, 65:1440-1448. 10.1111/j.1523-1755.2004.00534.x 15086487
114. Levy JB Turner AN Rees AJ Pusey CD Long term outcome of antiglomerular basement membrane antibody disease treated with plasma exchange and immunosuppression Ann Intern Med 2001, 134:1033-1042. 11388816
115. Austin HA 3rd Klippel JH Balow JE le Riche NG Steinberg AD Plotz PH Decker JL Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs N Engl J Med 1986, 314:614-619. 3511372
116. Ginzler E Dooley MA Aranow C Kim MY Buyon J Merrill JT Petri M Gilkeson GS Wallace DJ Weisman MH Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis N Engl J Med 2005, 353:2219-2228. 10.1056/NEJMoa043731 16306519
117. Smith KG Jones RB Burns SM Jayne DR Long term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: remission, relapse, and re-treatment Arthritis Rheum 2006, 54:2970-2982. 10.1002/art.22046 16947528
118. Candan S Pirat A Varol A Torgay A Zeyneloglou P Arslan G Respiratory problems in renal transplant recipients admitted to intensive care during long-term follow-up Transplant Proc 2006, 38:1354-1356. 10.1016/ j.transproceed.2006.02.083 16797301